Cargando…
Early differential responses elicited by BRAF(V600E) in adult mouse models
The BRAF gene is frequently mutated in cancer. The most common genetic mutation is a single nucleotide transition which gives rise to a constitutively active BRAF kinase (BRAF(V600E)) which in turn sustains continuous cell proliferation. The study of BRAF(V600E) murine models has been mainly focused...
Autores principales: | Bosso, Giuseppe, Lanuza-Gracia, Pablo, Piñeiro-Hermida, Sergio, Yilmaz, Merve, Serrano, Rosa, Blasco, Maria A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831492/ https://www.ncbi.nlm.nih.gov/pubmed/35145078 http://dx.doi.org/10.1038/s41419-022-04597-z |
Ejemplares similares
-
Telomerase deficiency and dysfunctional telomeres in the lung tumor microenvironment impair tumor progression in NSCLC mouse models and patient-derived xenografts
por: Piñeiro-Hermida, Sergio, et al.
Publicado: (2023) -
BRaf(V600E) cooperates with Pten silencing to elicit metastatic melanoma
por: Dankort, David, et al.
Publicado: (2009) -
BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma
por: Wilmott, J S, et al.
Publicado: (2013) -
BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
por: Del Bufalo, Francesca, et al.
Publicado: (2018) -
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
por: Al Hashmi, Muna, et al.
Publicado: (2020)